This is the authors' abstract. We don't add key points for this paper.
SHR controls for background glycemia and is a better biomarker of critical illness than absolute hyperglycemia. SHR identifies patients with relative hyperglycemia at risk of critical illness. Future studies should explore whether basing glucose-lowering therapy on relative, rather than absolute, hyperglycemia improves outcomes in hospitalized patients.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Roberts et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: